To summarise, we have investigated the prognostic significance of the angiogenic marker CD105 and its ligands TGFβ1 and TGFβ3 in patients with colorectal cancer by immunohistochemistry and ELISAs. This evidence concerns the gene TGFB3 and colorectal cancer.